Addex Therapeutics ($ADXN@Switzerland) will sell 3.75 million shares to Armistice Capital in the form of more than 600,000 American Depositary Shares at $6.50 per ADS. Each ADS represents 6 shares. Additionally, Addex will issue Armistice Capital warrants to purchase up to 9.23 million in the form of 1.54 million ADSs and pre-funded warrants to purchase up to nearly 5.5 million shares. The warrants have an exercise price of $6.50 per ADS. The gross proceeds to Addex will be $10 million. The company will use the net proceeds to advance its clinical and preclinical pipeline. The offering will close by December 21. Addex shares are down more than 7% at $6.66 during the premarket session on the last check Friday.
Comments